Drug Detail:Cetrotide (injectable) (Cetrorelix (injectable) [ se-troe-rel-ix ])
Generic Name: CETRORELIX ACETATE 0.25mg in 1mL;
Dosage Form: cetrorelix acetate
Drug Class: Gonadotropin-releasing hormone antagonists
Drug Detail:Cetrotide (injectable) (Cetrorelix (injectable) [ se-troe-rel-ix ])
Generic Name: CETRORELIX ACETATE 0.25mg in 1mL;
Dosage Form: cetrorelix acetate
Drug Class: Gonadotropin-releasing hormone antagonists
Ovarian stimulation therapy with gonadotropins (FSH, hMG) is started on cycle Day 2 or 3. The dose of gonadotropins should be adjusted according to individual response. Cetrotide® (cetrorelix acetate for injection) 0.25 mg may be administered subcutaneously once daily during the early- to mid-follicular phase.
Cetrotide® 0.25 mg is administered on either stimulation day 5 (morning or evening) or day 6 (morning) and continued daily until the day of hCG administration.
When assessment by ultrasound shows a sufficient number of follicles of adequate size, hCG is administered to induce ovulation and final maturation of the oocytes. No hCG should be administered if the ovaries show an excessive response to the treatment with gonadotropins to reduce the chance of developing ovarian hyperstimulation syndrome (OHSS).
Cetrotide® 0.25 mg can be administered by the patient herself after appropriate instructions by her doctor.